Scale-up– tag –
-
Cell Culture Technology
REPROCELL Accelerates Clinical-Grade iPSC Manufacturing Scale-Up with StemRNA™ Clinical Platform and AI-Driven StemEdit
REPROCELL Japan Overview REPROCELL is significantly accelerating the scale-up of clinical-grade induced pluripotent stem cell (iPSC) manufacturing by leveraging its proprietary StemRNA™ Clinical iPSC platform and AI-driven StemEdit gene-... -
Cell Culture Technology
Estonian Innovators ÄIO and TFTAK Secure €1.94M for DigiFoundry 2.0: Scaling Precision Fermentation for Cost-Efficient Microbial Oils
Industry News/Press Release Estonia Overview Estonian biotech ÄIO and applied research institution TFTAK have secured €1.94 million for their DigiFoundry 2.0 program, aiming to dramatically boost the efficiency and industrial scalability... -
New Technology
Corning Life Sciences Expands Advanced 3D Cell Culture and Bioprocess Solutions, Accelerating Research and Clinical Translation
Corning USA Overview Corning Life Sciences is continuously enhancing its portfolio of 3D cell culture models, stem cell research tools, bioprocess solutions, and cell therapy products. The company's offerings aim to replicate in vivo fun... -
Cell Culture Technology
KOLON Biotech Expands Comprehensive CDMO Services in Korea, Specializing in Cell, Gene, and Exosome Therapies
MTEC South Korea Overview KOLON Biotech in South Korea is bolstering its capabilities as a specialized Contract Development and Manufacturing Organization (CDMO) for advanced cell, gene, and exosome therapies. The company offers end-to-e... -
New Technology
Digital Twins Poised to Eclipse Traditional Scale-Up Models in Bioprocess Development
Pharma's Almanac USA Overview Pharma's Almanac suggests that digital twin technology may significantly outperform traditional models in bioprocess scale-up. Digital twins integrate process models with manufacturing and experimental data,... -
Cell Culture Technology
REPROCELL Enables Clinical-Scale iPSC Manufacturing with StemEdit and Bioreactor Technologies
REPROCELL Japan Overview REPROCELL is facilitating a seamless transition from lab-scale iPSC manufacturing to GMP production and clinical application by integrating its StemEdit gene-editing platform with ABLE Biott and BioThrust bioreac... -
New Technology
EU Project MODICA Innovates Bioprocess Scaling and Semi-Continuous Operation with Adaptive Digital Twin (ADT)
Modica EU Overview MODICA P.S.A., co-funded by EU funds, is developing an innovative Adaptive Digital Twin (ADT) for bioprocess modeling. This system integrates with modular bioreactor hardware components to enable efficient bioprocess s... -
Market Trends
Commercial-Scale iPSC Cell Therapy: Advancements in Off-the-Shelf Treatments, Immunogenicity, and Cost Reduction are Key
The Medicine Maker UK Overview This article examines the challenges and technological advances in scaling induced pluripotent stem cell (iPSC) platforms for commercial cell therapies. It highlights the shift towards allogeneic, off-the-s... -
New Technology
Endress+Hauser Boosts Single-Use Bioprocessing with Innovative Proline Promass U 500 Coriolis Flowmeter, Integrating Reusable Units with Disposable Sensors for Enhanced Flexibility
Endress+Hauser Switzerland Overview Endress+Hauser announced the Proline Promass U 500 Coriolis flowmeter as the latest innovation in single-use technology for bioprocessing. This groundbreaking technology combines a reusable base unit w... -
Cell Culture Technology
AuctuPrime: AuctuCel’s Chemically Defined Medium Standardizes Cell Therapy Production, Slashing Variability
The Manila Times Philippines Overview Singapore-based AuctuCel, in collaboration with Sperikon, has launched AuctuPrime, a groundbreaking chemically defined cell culture medium. This next-generation formulation eliminates the need for an...